Pharmacists

ORS 689.696
Prescription and dispensation of emergency refills of insulin

  • limitations
  • requirements
  • rules

(1)

As used in this section:

(a)

“Insulin” includes various types of insulin analogs and insulin-like medications, regardless of activation period or whether the solution is mixed before or after dispensation.

(b)

“Insulin-related devices and supplies”:

(A)

Includes needles, syringes, cartridge systems, prefilled pen systems, glucose meters and test strips.

(B)

Does not include insulin pump devices.
(2)(a) A pharmacist may prescribe and dispense emergency refills of insulin and associated insulin-related devices and supplies to a person who has evidence of a previous prescription from a licensed health care provider.

(b)

The insulin prescribed and dispensed under this section must be the lesser of a 30-day supply or the smallest available package.

(c)

A person may be prescribed and receive not more than three emergency refills of insulin and associated insulin-related devices and supplies in a calendar year.

(3)

A pharmacist who prescribes and dispenses emergency refills of insulin and associated insulin-related devices and supplies under this section shall:

(a)

Complete a training program approved by the State Board of Pharmacy that is related to prescribing emergency refills of insulin and associated insulin-related devices and supplies;

(b)

Complete a patient assessment to determine whether the prescription of emergency refills of insulin and associated insulin-related devices and supplies is appropriate;

(c)

Document the patient visit and include notations regarding evidence of the patient’s previous prescription from the patient’s licensed health care provider, information relating to the patient’s diabetes management and other relevant information; and

(d)

Make a reasonable attempt to inform the person’s primary care provider, and the licensed health care provider who made the previous prescription, of the pharmacist’s prescription for emergency refills of insulin and associated insulin-related devices and supplies.

(4)

The board shall adopt rules to carry out this section. In approving the training program described in subsection (3)(a) of this section, the board shall consult with and approve a training program accredited by the Accreditation Council for Pharmacy Education or its successor organization. [2019 c.95 §2]
Note: The amendments to 689.696 (Prescription and dispensation of emergency refills of insulin) by section 3, chapter 95, Oregon Laws 2019, become operative January 1, 2023. See section 8, chapter 95, Oregon Laws 2019. The text that is operative on and after January 1, 2023, is set forth for the user’s convenience.
689.696 (Prescription and dispensation of emergency refills of insulin). (1) As used in this section:

(a)

“Insulin” includes various types of insulin analogs and insulin-like medications, regardless of activation period or whether the solution is mixed before or after dispensation.

(b)

“Insulin-related devices and supplies”:

(A)

Includes needles, syringes, cartridge systems, prefilled pen systems, glucose meters and test strips.

(B)

Does not include insulin pump devices.
(2)(a) A pharmacist may prescribe and dispense emergency refills of insulin and associated insulin-related devices and supplies to a person who has evidence of a previous prescription from a licensed health care provider.

(b)

The insulin prescribed and dispensed under this section must be the lesser of a 30-day supply or the smallest available package.

(c)

A person may be prescribed and receive not more than three emergency refills of insulin and associated insulin-related devices and supplies in a calendar year.

(3)

A pharmacist who prescribes and dispenses emergency refills of insulin and associated insulin-related devices and supplies under this section shall:

(a)

Complete a patient assessment to determine whether the prescription of emergency refills of insulin and associated insulin-related devices and supplies is appropriate;

(b)

Document the patient visit and include notations regarding evidence of the patient’s previous prescription from the patient’s licensed health care provider, information relating to the patient’s diabetes management and other relevant information; and

(c)

Make a reasonable attempt to inform the person’s primary care provider, and the licensed health care provider who made the previous prescription, of the pharmacist’s prescription for emergency refills of insulin and associated insulin-related devices and supplies.

(4)

The board shall adopt rules to carry out this section.
Source

Last accessed
May 26, 2023

REMOVE ADS